Monitoring Blood Immune Cells in Patients with Advanced Small Cell Lung Cancer Undergoing a Combined Immune Checkpoint Inhibitor/Chemotherapy

In this exploratory prospective observational study on 40 small cell lung cancer (SCLC) patients treated with a combination of chemotherapy and immune checkpoint inhibitors, blood immune cells were characterized by multi-color flow cytometry at the baseline and at the third therapy cycle. The number...

Descripción completa

Detalles Bibliográficos
Autores principales: Riemann, Dagmar, Turzer, Steffi, Ganchev, Georgi, Schütte, Wolfgang, Seliger, Barbara, Möller, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953684/
https://www.ncbi.nlm.nih.gov/pubmed/36830562
http://dx.doi.org/10.3390/biom13020190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953684/
https://www.ncbi.nlm.nih.gov/pubmed/36830562
http://dx.doi.org/10.3390/biom13020190

Ejemplares similares